The modern management of esophageal cancer is crucially based on a multidisciplinary and multimodal approach. Radiotherapy is involved in neoadjuvant and adjuvant settings; moreover, it includes radical and palliative treatment intention (with a focus on the use of a stent and its potential integration with radiotherapy). In this review, the above-mentioned settings and approaches will be described. Referring to available international guidelines, the background evidence bases will be reviewed, and the ongoing, more relevant trials will be outlined. Target definitions and radiotherapy doses to administer will be mentioned. Peculiar applications such as brachytherapy (interventional radiation oncology), and data regarding innovative approaches including MRI-guided-RT and radiomic analysis will be reported. A focus on the avoidance of surgery for major clinical responses (particularly for SCC) is detailed.
Cellini, F., Manfrida, S., Casa, C., Romano, A., Arcelli, A., Zamagni, A., De Luca, V., Colloca, G. F., D'Aviero, A., Fuccio, L., Lancellotta, V., Tagliaferri, L., Boldrini, L., Mattiucci, G. C., Gambacorta, M. A., Morganti, A. G., Valentini, V., Modern Management of Esophageal Cancer: Radio-Oncology in Neoadjuvancy, Adjuvancy and Palliation, <<CANCERS>>, 2022; 14 (2): N/A-N/A. [doi:10.3390/cancers14020431] [http://hdl.handle.net/10807/203381]
Modern Management of Esophageal Cancer: Radio-Oncology in Neoadjuvancy, Adjuvancy and Palliation
Cellini, Francesco;Manfrida, Stefania;Romano, Angela;Colloca, Giuseppe Ferdinando;Tagliaferri, Luca;Boldrini, Luca;Mattiucci, Gian Carlo;Gambacorta, Maria Antonietta;Morganti, Alessio Giuseppe;Valentini, Vincenzo
2022
Abstract
The modern management of esophageal cancer is crucially based on a multidisciplinary and multimodal approach. Radiotherapy is involved in neoadjuvant and adjuvant settings; moreover, it includes radical and palliative treatment intention (with a focus on the use of a stent and its potential integration with radiotherapy). In this review, the above-mentioned settings and approaches will be described. Referring to available international guidelines, the background evidence bases will be reviewed, and the ongoing, more relevant trials will be outlined. Target definitions and radiotherapy doses to administer will be mentioned. Peculiar applications such as brachytherapy (interventional radiation oncology), and data regarding innovative approaches including MRI-guided-RT and radiomic analysis will be reported. A focus on the avoidance of surgery for major clinical responses (particularly for SCC) is detailed.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
